Cargando…

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer

OBJECTIVE: To investigate the clinical efficacy of neoadjuvant chemotherapy (NAC) with irinotecan (CPT-11) and nedaplatin (NED) followed by radical hysterectomy. METHODS: Patients with locally advanced cervical cancer (stage Ib2–IIb) were treated with NAC followed by surgery, primary surgery or prim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abou-Taleb, Hisham A, Koshiyama, Masafumi, Matsumura, Noriomi, Baba, Tsukasa, Yamaguchi, Ken, Hamanishi, Junzo, Abiko, Kaoru, Yamanoi, Koji, Murakami, Ryusuke, Horikawa, Naoki, Taha, Ahmed AA, Kitamura, Sachiko, Konishi, Ikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Clinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580053/ https://www.ncbi.nlm.nih.gov/pubmed/26831404 http://dx.doi.org/10.1177/0300060515591858

Ejemplares similares

Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients
por: Horikawa, Naoki, et al.
Publicado: (2015)

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer
por: Yamanoi, Koji, et al.
Publicado: (2016)

Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics
por: Konishi, Ikuo, et al.
Publicado: (2022)

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
por: Hamanishi, Junzo, et al.
Publicado: (2016)

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
por: Horikawa, Naoki, et al.
Publicado: (2020)

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
por: Taki, Mana, et al.
Publicado: (2018)

Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
por: Nagura, Michikazu, et al.
Publicado: (2014)

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer
por: Yamanoi, Koji, et al.
Publicado: (2019)

Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
por: Murakami, Ryusuke, et al.
Publicado: (2021)

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma
por: Abou-Taleb, Hisham, et al.
Publicado: (2016)

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
por: Ohsuga, Takuma, et al.
Publicado: (2017)

PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
por: Kitamura, Sachiko, et al.
Publicado: (2021)

Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma
por: Inoue, Ayami, et al.
Publicado: (2017)

Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer
por: Sakae, Chieko, et al.
Publicado: (2016)

Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival
por: Amano, Yasuaki, et al.
Publicado: (2015)

UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study
por: Matsuoka, Hideki, et al.
Publicado: (2020)

VISTA expressed in tumour cells regulates T cell function
por: Mulati, Kumuluzi, et al.
Publicado: (2018)

B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
por: Miyamoto, Taito, et al.
Publicado: (2022)

Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report
por: AMANO, YASUAKI, et al.
Publicado: (2013)

Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes
por: Kitamura, Sachiko, et al.
Publicado: (2017)

Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images
por: Nakamura, Mitsuhiro, et al.
Publicado: (2020)

Corrigendum to “Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images”
por: Nakamura, Mitsuhiro, et al.
Publicado: (2021)

The effect of the type of dietary protein on the development of ovarian cancer
por: Taha, Ahmed A.A., et al.
Publicado: (2018)

Clinical Efficacy of Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2016)

Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
por: Koshiyama, Masafumi, et al.
Publicado: (2014)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
por: So, Makiko, et al.
Publicado: (2019)

Four cases of endometrioid borderline ovarian tumour: case reports and literature review
por: Nakagawa, Eriko, et al.
Publicado: (2017)

Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
por: Yamaguchi, Ken, et al.
Publicado: (2021)

CXCL13-producing CD4(+) T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer
por: Ukita, Masayo, et al.
Publicado: (2022)

A 36 kg Giant Ovarian Fibroma with Meigs Syndrome: A Case Report and Literature Review of Extremely Giant Ovarian Tumor
por: Tanaka, Miyu, et al.
Publicado: (2021)

Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer
por: Tsuda, H, et al.
Publicado: (2004)

A Case of Torsion in an Otherwise-Normal Ovary with a Giant Hematosalpinx Larger than Enlarged Ovary: Utilization of Diagnostic Laparoscopy for the Accurate Diagnosis
por: Yu, Sae, et al.
Publicado: (2021)

Nedaplatin: a cisplatin derivative in cancer chemotherapy
por: Shimada, Muneaki, et al.
Publicado: (2013)

Superradical Hysterectomy for Cervical Cancer as an Alternative to the Usual Okabayashi-Type Radical Hysterectomy
por: Mandai, Masaki, et al.
Publicado: (2021)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2021)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
por: Qin, Meng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kt488epkhd8vnh4kl57p54o9a8